Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function — role of glucose metabolism and insulin signalling
The DOI matches its Crossref record; 105 of the 106 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most frequent form of dementia among the elderly and is characterized by neuropathological hallmarks of extracellular amyloid-beta (Abeta) plaques and intracellular neurofibrillary tangles composed of abnormally hyperphosphorylated microtubular protein tau in the brains of AD patients. Of note, current data illustrate a complex interplay between the amyloid and tau pathology during the course of the disease. We hypothesize a direct impact of abnormally phosphorylated tau and Abeta on proteins/enzymes involved in metabolism, respiratory chain function and cellular detoxification. Probably at the level of mitochondria, both Alzheimer proteins exhibit synergistic effects finally leading to/accelerating neurodegenerative mechanisms. Moreover, accumulating evidence that mitochondria failure, reduced glucose utilization and deficient energy metabolism occur already very early in the course of the disease suggests a role of impaired insulin signalling in the pathogenesis of AD. Thus, this review addresses also the question if mitochondrial dysfunction may represent a link between diabetes and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Abnormalities in mitochondrial function are associated with neurodegenerative disorders including Parkinson's disease [133], Alzheimer's disease [134] and Huntington's disease [135].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [134]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 2×
“Several studies have demonstrated neurotoxic/synaptotoxic properties of these small and freely diffusible oligomeric assemblies (Walsh et al., 2002; Lacor et al., 2004).”
BackgroundStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 1×
“However, ApoE e4 allele presence is neither necessary nor sufficient to cause AD (Strittmatter et al., 1993).”
BackgroundBlennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · cited 4×
“In long- itudinal studies following large populations prospec- tively, type 2 diabetes subjects as compared to the non-diabetic control group have double the risk of AD (Leibson et al., 1997; Ott et al., 1999; Grodstein et al., 2001; Peila et al., 2002; Arvanitakis et al., 2004; Xu et al., 2004).”
BackgroundInfluentialSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“Correspondingly, a meta-analysis confirmed a significant association of IDE with AD (Bertram et al., 2007).”
BackgroundSteen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 4×
“Abnormalities in insulin, IGF I and II were associated with reduced levels of insulin receptor substrate mRNA, tau mRNA, insulin receptor substrate-associated phosphotidylinositol 3-kinase, and phospho-Akt (activated), increased glycogen synthase kinase-3b activity and APP mRNA expression (Steen et al., 2005).”
BackgroundInfluentialFormation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · cited 6×
“Important evidence has been provided by Gotz and coworkers demonstrating that Ab induces PHF-like tau filaments in tissue culture and the formation of NFT in P301L mice (Gotz et al., 2001; Ferrari et al., 2003) (Figure 2).”
BackgroundInfluentialMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 2×
“, 2004) and the observations of mitochondrial structural abnormalities (Hirai et al., 2001).”
BackgroundInfluential
Research works printed but not linked: 3
- Authier F, 1996, Clin Invest Med, 19, 149
- Fernandez-Vizarra P, 2004, Histol Histopathol, 19, 823
- Herholz K, 2002, J Nucl Med, 43, 21
Cited by
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Ferulic acid: Pharmacological and toxicological aspects
Mancuso, C., & Santangelo, R. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.024 · Cited by 572
Sultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478
“TheoligomericformofAbspeciesinterferesinmole- cularandbiochemicalalterationsinADmoresothantheextracellular ,insolubleamyloiddeposits[156] [157] [158],suggestingthat Ab-inducedmitochondrialdysfunctioncanplayamajorrolein ADprogressionandpathogenesis[159] [160] [161].”
De-Paula, V. J., Radanovic, M., Diniz, B. S., & Forlenza, O. V. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-5416-4_14 · Cited by 405
Interaction of aldehydes derived from lipid peroxidation and membrane proteins
Pizzimenti, S., Ciamporcero, E., Daga, M., Pettazzoni, P., Arcaro, A., Cetrangolo, G., Minelli, R., Dianzani, C., Lepore, A., Gentile, F., et al. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00242 · Cited by 380
“Reduced glucose utilization and energy production (Rhein and Eckert, 2007) are early occurrences in AD.”
Background
Metadata
- Authors
- Rhein, V., & Eckert, A.
- Affiliations
- Universitäre Psychiatrische Kliniken Basel (CH)
- ORCID
- Eckert, Anne
- Venue
- Archives of Physiology and Biochemistry
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 113
- Issue
- 3
- Pages
- 131-141
- ISSN
- 0778-3124 (ISSN-L)
- 1381-3455
- 1744-4160
- OpenAlex
- W2010198459
- Semantic Scholar
- fbc95bfe2b5ec9e2c8b3aca9b791721b0096df1c
- Cited by
- 56
- References
- 106
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 5 · 2012: 5
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Physiology and Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, tau protein, mitochondrial dysfunction, glucose metabolism, insulin signaling, neurofibrillary tangles, energy metabolism, diabetes mellitus, neurodegeneration, electron transport chain, cellular detoxification
- MeSH terms
- Alzheimer Disease, Brain, Humans, Insulin, Mitochondria, Somatomedins, Signal Transduction, Amyloid beta-Peptides, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function — role of glucose metabolism and insulin signalling. https://app.cochat.ai/papers/10.1080/13813450701572288
- The paper
- Rhein, V., & Eckert, A. (2007). Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function — role of glucose metabolism and insulin signalling. Archives of Physiology and Biochemistry. https://doi.org/10.1080/13813450701572288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.